NEW YORK, N.Y.–Israel Cancer Research Fund ( ICRF) has announced funding for 69 cancer research grants, valued at $4,711,335, that will be supported for the 2020-2021 funding year. 

The new grants include: the first Career Development Award (CDA) for a young clinician-scientist, co-funded with Conquer Cancer (The ASCO Foundation), as well as two new International Collaboration Grants for an Israeli scientist partnering with a U.S.-based scientist, co-funded with The Samuel Waxman Cancer Research Foundation and The Alan B. Slifka Foundation, and two new Gesher Grants for Israeli scientists returning to Israel after studying abroad, co-funded by ICRF Israel and The Israel Ministry of Science and Technology (MOST).

With the 2020-2021 grants, ICRF’s funding has now surpassed 2,500 grants totaling more than $77.5 million. ICRF’s volunteer Scientific Review Panel (SRP), composed of leading American and Canadian scientists with expertise in cancer research. After a lengthy peer-review process, the SRP presents its rankings to the International Scientific Council (ISC), ICRF’s scientific policy-making arm. In turn, the ISC forwards its recommendations to the International Board of Trustees for ratification. Grant selection is based on the scientific merit of the proposed research and the quality of the application. ICRF has funded projects at virtually all of the leading research centers in Israel, and has become the largest non-governmental funder of cancer research in Israel.

Among the areas of cancer research sponsored by ICRF in 2020-21 are studies in blood, brain, breast, colorectal, lung, ovarian, pancreatic, pediatric, and skin cancers, as well as genetics and genomics, molecular biology, immunology and immunotherapy, and the tumor microenvironment.

For more information, contact Beth Belkin at (917) 225-9604 or Beth_Belkin@hotmail.com.